100
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Under-Prescription of Allergen-Immunotherapy: Why is it Important to Prescribe it in Childhood Instead?

ORCID Icon &
Pages 359-361 | Received 19 Oct 2020, Accepted 06 Jan 2021, Published online: 13 Jan 2021

References

  • European Federation of Allergy and Airways Diseases Patients Associations . EFA Book on Respiratory Allergies.ValovirtaE ( Ed.). Basic Facts, Brussels, Belgium (2011).
  • Muraro A , RobertsG , HalkenSet al. EAACI guidelines on allergen immunotherapy: executive statement. Allergy73(8), 739–743 (2018).
  • Brożek JL , BousquetJ , AgacheIet al. Allergic rhinitis and its impact on asthma (ARIA) guidelines-2016 revision. J. Allergy Clin. Immunol.140(2), 950–958 (2017).
  • Global Initiative for Asthma . GINA guidelines, 2020. Global strategy for asthma management and prevention. (2020). www.ginasthma.org/
  • European Medicine Agency . Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases. EMA, London, UK (2008). ( CHMP/EWP/18504/2006).
  • WHO Position Paper . Allergen immunotherapy: therapeutic vaccines for allergic diseases. Geneva: January 27–29, 1997. Allergy53(Suppl. 44), 1–42 (1999).
  • Shamji MH , DurhamSR. Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers. J. Allergy Clin. Immunol.140(3), 1485–1498 (2017).
  • Bearings M , KaraaslanC , AltunbulakliCet al. Advances and highlights in allergen immunotherapy: on the way to sustained clinical and immunologic tolerance. J. Allergy Clin. Immunol.140(3), 1250–1267 (2017).
  • Akdis CA , AkdisM. Mechanisms of allergen-specific immunotherapy and immune tolerance to allergens. World Allergy Organ J.8, 17 (2015).
  • Kappen JH , DurhamSR , VeenHI , ShamjiMH. Applications and mechanisms of immunotherapy in allergic rhinitis and asthma. Ther. Adv. Respir. Dis.11(4), 73–86 (2017).
  • van de Veen W , WirzOF , GlobinskaA , AkdisM. Novel mechanisms in immune tolerance to allergens during natural allergen exposure and allergen-specific immunotherapy. Curr. Opin. Immunol.48(1), 74–81 (2017).
  • Cox L , NelsonH , LockeyRet al. Allergen immunotherapy: a practice parameter third update. J. Allergy Clin. Immunol.127(5), S1–S55 (2011).
  • Filipovic ID , CaminatiM , KosticG , FilipovicD , ZivkovicZ. Allergen-specific sublingual immunotherapy in children with asthma and allergic rhinitis. World J. Pediatr.12(4), 283–290 (2016).
  • Miraglia Del Giudice M , LicariA , BrambillaI , ToscaMA , CiprandiG. Allergen immunotherapy in pediatric asthma: a pragmatic point of view. Children (Basel).7(6), 58 (2020).
  • Cox LS , MurpheyA , HankinC. The cost–effectiveness of allergen immunotherapy compared with pharmacotherapy for treatment of allergic rhinitis and asthma. Immunol. Allergy Clin. North Am.40(1), 69–85 (2020).
  • Porri E . Malattia allergica e immunoterapia specifica con allergeni (AIT), Centro Studi Assobiomedica, Studi N. 29. (2014).
  • Sestini P , DeSario M , BugianiMet al. Frequency of asthma and allergies in Italian children and adolescents: results from SIDRIA-2]. Epidemiol. Prev.29(Suppl. 2), 24–31 (2005).
  • Bresciani S , BrunettoB , IacovacciPet al. Prevalence of self-perceived allergic diseases and risk factors in Italian adolescents. Pediatr. Allergy Immunol.20(6), 578–584 (2009).
  • Tosca MA , MarsegliaGL , CiprandiG. The treatment of allergic rhinitis in asthmatic children and adolescents: practical outcomes from the real-world “ControL’Asma” study. Eur. Ann. Allergy Clin. Immunol.(2020) ( In Press).
  • Tosca MA , MarsegliaGL , CiprandiG. The real-world “ControL’Asma” study: a nationwide taskforce on asthma control in children and adolescents. Allergologia Immunopathol. (2020) ( In Press).
  • Barberi S , BernardoL , D’AuriaEet al. Allergen immunotherapy and respiratory infections in children: an encouraging experience. Minerva Pediatr.70(1), 1–4 (2018).
  • Kaul S , LuttkopfD , ViethsS. Regulatory environment for allergen-specific immunotherapy. Allergy66, 753–764 (2011).
  • Rose K , KoppMV. Pediatric investigation plans for specific immunotherapy: questionable contributions to childhood health. Pediatr. Allergy Immunol.26, 695–701 (2015).
  • Rose K , Grant-KelsJM. The meaning of “pediatric drug development”. Ther. Innov. Regul. Sci.53(6), 767–774 (2019).
  • Rose K . The challenges of pediatric drug development. Curr. Ther. Res. Clin. Exp.90, 128–134 (2019).
  • Pfaar O , AgacheI , de BlayFet al. Perspectives in allergen immunotherapy: 2019 and beyond. Allergy74(Suppl. 108), 3–25 (2019).
  • Ricklefs I , Hohmann-EbbersM , HerzA , KoppMV. Use of complementary and alternative medicine in children with asthma. Pediatr. Allergy Immunol.29(3), 326–328 (2018).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.